Thursday, December 3, 2020
Home Life Style Health & Fitness New Treatment Developed for Lung Fibrosis

New Treatment Developed for Lung Fibrosis

Idiopathic Pulmonary Fibrosis (IPF) is also called lung fibrosis

Lung fibrosis — a condition in which the lungs become scarred over time — has been a concern for COVID-19 patients, say, researchers, adding that they have now developed a new treatment option for lung fibrosis.

Lung fibrosis’ symptoms include shortness of breath, dry cough, feeling tired, weight loss, and nail clubbing. Complications may include pulmonary hypertension, respiratory failure, pneumothorax, and lung cancer.

Follow NewsGram on Twitter to stay updated about the World news.

People with Idiopathic Pulmonary Fibrosis (IPF), also called lung fibrosis, have a life expectancy of fewer than five years. Fibrotic diseases cause organ failure leading to nearly 45 percent of all deaths in the U.S. Existing therapies to do little to slow the progression.

Now the research team from Purdue University, US, has developed two targeted therapies for people with IPF.

Follow NewsGram on Instagram to keep yourself updated.

The two different therapeutic approaches are published in the journals — Science Translational Medicine and EMBO Molecular Medicine.

Lung Fibrosis
The developments come as a number of people with COVID-19 or who have recovered from COVID-19 experienced lung fibrosis or other related conditions. Pixabay

“This is a horrible disease that claimed the lives of my neighbor next-door and a good friend’s wife,” said a study author Philip S. Low of Purdue University.

Want to read more in Hindi? Checkout: वाणी कपूर ने समझा व्यस्त रहने का दूसरा पहलू

“We developed two targeted therapies that allow us to use powerful drugs with high toxicities because we specifically deliver them to diseased cells without harming healthy ones,” Low added.

The first of the Purdue team’s novel targeted molecules are designed to slow fibrosis and extends life. The second IPF therapy suppresses fibrosis-inducing cytokine production.

The two therapies will be moving into human clinical trials within the next several months.

ALSO READ: Social Distancing Is Increasing Feelings Of Loneliness In Old People

The developments come as a number of people with COVID-19 or who have recovered from COVID-19 experienced lung fibrosis or other related conditions. (IANS)



Most Popular

What Does the Music Industry Look Like In 2021?

Whether it’s shuffling through songs on their iTunes playlist, discovering new beats on Spotify, or tuning into Instagram Live to see their favorite musicians...

Companies Need More Strength in Cyber Security

As the Covid pandemic has brought about a sea change in the operations of most companies with work from home becoming the trend over...

Yogi Proposes World Class Film City in Noida

Uttar Pradesh Chief Minister Yogi Adityanath said on Wednesday that the proposed film city in Noida would offer 'world-class' facilities to the entertainment industry. The...

Does Counting Cards in Blackjack Work?

Card counting is one of the ways to win at blackjack. But does counting cards in blackjack work? Well, there are a lot of...

No Risk Of Nanoparticles In Sunscreen Sprays

People can continue using mineral-based aerosol sunscreens without fear of exposure to dangerous levels of nanoparticles or other respirable particulates, say researchers. The findings...

Pets Played Lifesaving Role During Covid19 Pandemic: Study

In the absence of human-to-human contact, in millions of households worldwide, animals or pets have provided much-needed comfort via cuddles, pats, and a constant...

Digital December: OTT Platforms Are Back With A Bang This December

Digital platforms have provided relief and joy in a year engulfed by pandemic and lockdown. The mood continues into the last month of 2020...

One In Two Urban Indians Are Early Adopters Of Technology

One in two urban Indians, predominantly young and affluent, are early adopters of technology and are eager to buy new products as well as...

Recent Comments